Interpretation of 2-[18F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors

Manson, G., Lemchukwu, A. C., Mokrane, F.-Z., Lopci, E., Aide, N., Vercellino, L., Houot, R., & Dercle, L. (2022). Interpretation of 2-[18F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors. European Radiology, 32(9), 6536–6544. https://doi.org/10.1007/s00330-022-08669-8
Authors:
Guillaume Manson
Amaeshi Chukwunonye Lemchukwu
Fatima-Zohra Mokrane
Egesta Lopci
Nicolas Aide
Laetitia Vercellino
Roch Houot
Laurent Dercle
Affiliated Authors:
Laurent Dercle
Subjects:
Author Keywords:
hodgkin lymphoma
immunotherapy
immune checkpoint inhibitors
pet
pseudoprogression indeterminate response
Publication Type:
Article
Unique ID:
10.1007/s00330-022-08669-8
PMID:
Publication Date:
Data Source:
PubMed

Record Created: